• Products
    • Elisa Kits
    • CLIA Kit
    • PCR Kit
    • Secondary Antibody
    • Polyclonal Antibody
    • Monoclonal Antibody
  • Ordering
  • About Us
  • Contact us
MyBioSource Learning Center
  • Home
  • Research Surveys
  • Testing Procedures
  • ELISA Testing
    • Choosing the Right ELISA Kit
    • Elisa Assays in Pharmaceutical and Biotechnological Research
    • ELISA Sensitivity and Specificity
    • Best Practices for ELISA Sample Handling
    • ELISA Evolution
    • ELISA Assay Challenges
    • ELISA: Data Analysis and Interpretation
  • Blog
Select Page
WHO demands more funds to combat Malaria

WHO demands more funds to combat Malaria

by MyBiosource Editorial Team | Dec 4, 2017 | Uncategorized

            Table of Contents I. Introduction II. Funding Shortages for Malaria Control • The Current Funding Situation • The Target Funding Needed to Meet WHO’s Malaria Strategy III. Malaria Cases and Deaths IV. Malaria Control...

Opiod Overdose Deaths, 2013-2015, Per 100K People, US States

by MyBiosource Editorial Team | Dec 4, 2017 | Uncategorized

  Location 2013 2014 2015 Alabama 12.7 15.2 15.7 Alaska 14.4 16.8 16 Arizona 18.7 18.2 19 Arkansas 11.1 12.6 13.8 California 11.1 11.1 11.3 Colorado 15.5 16.3 15.4 Connecticut 16 17.6 22.1 Delaware 18.7 20.9 22 District of Columbia 15 14.2 18.6 Florida 12.6 13.2...

Opiod Overdose Deaths, 2013-2015, Absolute Numbers, US States

by MyBiosource Editorial Team | Dec 4, 2017 | Uncategorized

Location 2013 2014 2015 Alabama 598 723 736 Alaska 105 124 122 Arizona 1,222 1,211 1,274 Arkansas 319 356 392 California 4,452 4,521 4,659 Colorado 846 899 869 Connecticut 582 623 800 Delaware 166 189 198 District of Columbia 102 96 125 Florida 2,474 2,634 3,228...

Opiod Prescription Rate per 100 US Residents, 2011 – 2016

by MyBiosource Editorial Team | Dec 4, 2017 | Uncategorized

US States Opiod Prescription Rates, 2011 – 2016, Note: Estimated rate of opioid prescriptions per 100 U.S. residents State 2011 2012 2013 2014 2015 2016 Alabama 136.6 143.8 142.4 135.2 125 121 Alaska 68 66.8 63.7 62.7 60.8 58.9 Arizona 88.6 85.3 80.4 79.7 75.5...

US FDA Approves Mylan-Biocon’s Ogivri for stomach and breast cancer treatment

by MyBiosource Editorial Team | Dec 3, 2017 | Uncategorized

Table of Contents I. Introduction II. FDA Commissioner’s Statement III. Mylan and Biocon Collaboration • Overview of the six biologic products developed • Comparison of Ogivri to Roche’s Herceptin IV. Breast Cancer Statistics and Symptoms • Number of breast cancer...

WHO combats Yellow Fever in Nigeria

by MyBiosource Editorial Team | Dec 2, 2017 | Uncategorized

Table of Contents I. Introduction II. Yellow fever outbreaks in Nigeria, Angola, and the Democratic Republic of Congo III. Countries at risk of yellow fever IV. Transmission and Symptoms of Yellow Fever V. Prevention and Treatment of Yellow Fever VI. Incubation Time...
« Older Entries
Next Entries »

Recent Posts

  • ELISA Sensitivity and Specificity
  • Sips Surge
  • ELISA Evolution
  • ELISA: Data Analysis and Interpretation
  • ELISA: Qualitative vs. Quantitative
  • Advancements in ELISA Assay Technology
  • Comparing Other Immunoassay with Elisa
  • ELISA Assay Challenges
  • Best Practices for ELISA Sample Handling
  • Choosing the Right ELISA Kit
  • Facebook
  • X
  • RSS
Trending Kits (IL-6 elisa kit, INS elisa kit), CRP elisa kit, TDO2 elisa kit, TDO elisa kit)